|

DAY 1 | Breast cancer

{{ getTitle(live) }}

{{ toDate(live.liveStartDate) }}

{{ toTime(live.liveStartDate) }} - {{ toTime(live.liveEndDate) }}


{{ getNotification(live) }}

Programme Friday, October 1: Update on the treatment of breast cancer

 

19:30  Welcome
   
19:30 - 20:30 Part 1 – Update on early breast cancer
  Moderator: Prof. Dr. Patrick Neven, UZ Leuven
19:30 New data in the radiotherapeutic approach of early breast cancer
  Prof. Dr. Liv Veldeman, UZ Ghent
19:40  Panel discussion
19:50 New data in the treatment of HER2-early breast cancer patients
  Prof. Dr. Guy Jerusalem, CHU Liège
20:05 New data in the treatment of HER2+ or Triple negative early breast cancer patients
  Prof. Dr. Peter van Dam, UZ Antwerp
20:20  Panel discussion
20:40 Break
   
20:50 – 22:05 Part 2 – Update on metastatic breast cancer
  Moderator: Prof. Dr. Hannelore Denys, UZ Ghent
20:50   New data in luminal disease
  Prof. Dr. François Duhoux, UC Louvain, Brussels
  + Panel discussion
21:15 New data in HER2 + disease
  Dr. Donatienne Taylor, CHU Namur
  + Panel discussion
21:40 New data in triple negative disease
  Dr. Kevin Punie, UZ Leuven
  + Panel discussion
22:05 Close

 

Panel

Prof. Dr. Patrick Neven

Prof. Dr. Patrick Neven

UZ Leuven

Prof. Dr. Liv Veldeman

Prof. Dr. Liv Veldeman

UZ Ghent

Prof Dr. Guy Jerusalem

Prof Dr. Guy Jerusalem

CHU Liège

Prof. Dr. Hannelore Denys

Prof. Dr. Hannelore Denys

UZ Ghent

Prof. Dr. François Duhoux

Prof. Dr. François Duhoux

UC Louvain, Brussels

Dr. Donatienne Taylor

Dr. Donatienne Taylor

CHU Namur

Dr. Kevin Punie

Dr. Kevin Punie

UZ Leuven

Prof. Peter van Dam

Prof. Peter van Dam

UZ Antwerp

Programme Friday, October 1: Update on the treatment of breast cancer

 

19:30  Welcome
   
19:30 - 20:30 Part 1 – Update on early breast cancer
  Moderator: Prof. Dr. Patrick Neven, UZ Leuven
19:30 New data in the radiotherapeutic approach of early breast cancer
  Prof. Dr. Liv Veldeman, UZ Ghent
19:40  Panel discussion
19:50 New data in the treatment of HER2-early breast cancer patients
  Prof. Dr. Guy Jerusalem, CHU Liège
20:05 New data in the treatment of HER2+ or Triple negative early breast cancer patients
  Prof. Dr. Peter van Dam, UZ Antwerp
20:20  Panel discussion
20:40 Break
   
20:50 – 22:05 Part 2 – Update on metastatic breast cancer
  Moderator: Prof. Dr. Hannelore Denys, UZ Ghent
20:50   New data in luminal disease
  Prof. Dr. François Duhoux, UC Louvain, Brussels
  + Panel discussion
21:15 New data in HER2 + disease
  Dr. Donatienne Taylor, CHU Namur
  + Panel discussion
21:40 New data in triple negative disease
  Dr. Kevin Punie, UZ Leuven
  + Panel discussion
22:05 Close